TOP NEWShttps://www.prnewswire.com/news-releases/telesta-therapeutics-announces-south-korean-partnership-for-mcna--concurrent-private-placement-517526211.html Telesta Therapeutics Announces South Korean Partnership for MCNA & Concurrent Private Placement Dr. Michael Berendt, Chief Executive Officer and Chief Scientist commented: "We are pleased to have established this relationship with BL&H whose established track record of successful registrations, market access and launches of oncology and specialty products in South Korea were the deciding factors in our decision to choose to work with them for the launch of MCNA in this important market. This regional transaction represents our first transaction as we continue our discussions with potential strategic partners for all of the key global markets and as we move MCNA towards a near term regulatory approval in the United States, the world's largest pharmaceutical market."